| 3226 |
Mitsui Fudosan Accommodation Fund Inc.
|
M&A |
|
Notice Regarding Completion of Domestic Real Estate Transfer (Park Axis Takamiya Higashi)
|
Feb 20, 2026
|
| 4530 |
Hisamitsu Pharmaceutical Co., Inc.
|
M&A |
|
Notice Regarding the Results of the Tender Offer by Taiyo Kosan Co., Ltd. for Our Shares and the Change in Parent Company, Major Shareholder, Principal Shareholder and Major Shareholders
|
Feb 20, 2026
|
| 2216 |
Kanro Co., Ltd.
|
Other |
|
Matters Concerning Controlling Shareholders and Others
|
Feb 20, 2026
|
| 1301 |
Kyokuyo Co., Ltd.
|
Personnel |
|
Notice Regarding Changes in Executive Officers
|
Feb 20, 2026
|
| 1301 |
Kyokuyo Co., Ltd.
|
Personnel |
|
Notice Regarding Changes in Officers
|
Feb 20, 2026
|
| 3673 |
BroadrLeaf Co., Ltd.
|
Dividend |
|
Notice Regarding Dividend of Surplus
|
Feb 20, 2026
|
| 2004 |
Showa Sangyo Co., Ltd.
|
Personnel |
|
Notice Regarding Change of Representative Director
|
Feb 20, 2026
|
| 3382 |
Seven & i Holdings Co., Ltd.
|
Share Buyback |
|
Notice Regarding Status of Share Buyback and Completion of Acquisition
(Share Buyback Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Feb 20, 2026
|
| 3825 |
Remixpoint, Inc.
|
Strategy |
|
Notice Regarding the Commencement of Bitcoin Management Utilizing Lending Services Based on Partnership with SBI Digital Finance
|
Feb 20, 2026
|
| 7236 |
Tilad Corporation
|
Earnings |
|
Notice Regarding the Financial Results of the Unlisted Parent Company
|
Feb 20, 2026
|
| 9010 |
Fujikyu Corporation
|
Other |
|
(Revision) Notice Regarding the Sale of Shares of Missing Shareholders
|
Feb 20, 2026
|
| 1379 |
Hokuto Corporation
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Presentation Materials
|
Feb 20, 2026
|
| 8053 |
Sumitomo Corporation
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition, Completion of Acquisition, and Number of Cancelled Shares
(Based on the Articles of Incorporation under the Provisions of Article 165, Paragraph 2 of the Companies Act
and Cancellation of Treasury Stock Based on the Provisions of Article 178 of the Companies Act)
|
Feb 20, 2026
|
| 4894 |
QUOLIPS, Inc.
|
Strategy |
|
Status of Manufacturing and Marketing Approval Review for Human (Allogeneic) iPS Cell-Derived Cardiomyocyte Sheets
|
Feb 19, 2026
|
| 3479 |
TKP Corporation
|
Other |
|
Notice Regarding Partial Change to the Shareholder Benefits Program
|
Feb 19, 2026
|
| 3279 |
Activia Properties Inc.
|
Other |
|
Notice Regarding Borrowing of Funds
|
Feb 19, 2026
|
| 9347 |
Nippon Kanzai Holdings Co., Ltd.
|
Personnel |
|
Notice Regarding Changes in Executive Responsibilities, Organizational Restructuring, and Personnel Transfers
|
Feb 19, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
M&A |
|
(Amendment) Notice Regarding the Abolition of the Investor Benefits Program
|
Feb 19, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
M&A |
|
Notice Regarding the Amount and Scheduled Timing of Payment Expected to be Delivered for the Tender Offer by Tiger Investment Limited Partnership and Lion Investment Limited Partnership for Investment Units of Sankei Real Estate Investment Corporation (Securities Code: 2972)
|
Feb 19, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
M&A |
|
(Amendment) Notice of Partial Amendment to the Opinion of Support and Recommendation for Subscription Regarding the Tender Offer for Investment Units of Sankei Real Estate Investment Corporation (Securities Code: 2972) by Tiger Investment Limited Partnership and Lion Investment Limited Partnership
|
Feb 19, 2026
|
